I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage NonSmall Cell Lung Cancer

被引：0

作者：

Saad, M. B. ^{[1
]}

Showkatian, E. ^{[1
]}

Al-Tashi, Q. ^{[1
]}

Aminu, M. ^{[1
]}

Xinyan, X. ^{[1
]}

Mohamed, M. Qayati ^{[1
]}

Salehjahromi, M. ^{[1
]}

Sujit, S. J. ^{[1
]}

Lin, S. H. ^{[2
]}

Liao, Z. ^{[2
]}

Gandhi, S. ^{[2
]}

Qian, D. ^{[2
]}

Jaffray, D. A. ^{[1
,3
]}

Chung, C. ^{[2
,3
]}

Vokes, N. ^{[4
]}

Zhang, J. ^{[4
]}

Heymach, J. V. ^{[4
]}

Wu, J. ^{[1
,3
,4
]}

Chang, J. Y. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Inst Data Sci Oncol, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

SABR; Immunotherapy; Radiomics;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA13.05

引用

页码：S40 / S40

页数：1

共 50 条

[31] A deep-learning radiomics model for predicting survival in early-stage non-small cell lung cancer.
Chaunzwa, Tafadzwa Lawrence
Christiani, David C.
Lanuti, Michael
Shafer, Andrea
Diao, Nancy
Mak, Raymond H.
Aerts, Hugo
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[32] Stage I and II nonsmall cell lung cancer treatment options
Hardavella, Georgia
Magouliotis, Dimitrios E.
Chalela, Roberto
Januszewski, Adam
Dennstaedt, Fabio
Putora, Paul Martin
So, Alfred
Bhowmik, Angshu
BREATHE, 2024, 20 (02)
[33] Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer
Yucheng Zhang
Anastasia Oikonomou
Alexander Wong
Masoom A. Haider
Farzad Khalvati
Scientific Reports, 7
[34] International expert consensus on immunotherapy for early-stage non-small cell lung cancer
Liang, Wenhua
Cai, Kaican
Cao, Qingdong
Chen, Chun
Chen, Haiquan
Chen, Jun
Chen, Ke-Neng
Chen, Qixun
Chu, Tianqing
Dong, Yuchao
Fan, Jiang
Fang, Wentao
Fu, Junke
Fu, Xiangning
Gao, Shugeng
Ge, Di
Geng, Guojun
Geng, Qing
He, Jie
Hu, Jian
Hu, Jie
Hu, Wei-Dong
Jiang, Feng
Jiang, Tao
Jiao, Wenjie
Li, He-Cheng
Li, Qiang
Li, Shanqing
Li, Shuben
Li, Xiangnan
Liao, Yong-De
Liu, Changhong
Liu, Hongxu
Liu, Yang
Lu, Zhuming
Luo, Qingquan
Ma, Haitao
Pan, Xiaojie
Qiao, Guibin
Ren, Shengxiang
Shen, Weiyu
Song, Yong
Sun, Daqiang
Wang, Guangsuo
Wang, Jie
Wang, Mengzhao
Wang, Qiwen
Wang, Wen-Xiang
Wei, Li
Wu, Ming
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (09) : 1742 - 1762
[35] The beginning of the perioperative immunotherapy era in early-stage non-small cell lung cancer
Riano, Ivy
Dragnev, Konstantin H.
Phillips, Joseph D.
TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (11) : 2359 - 2365
[36] How to Select Patients With Clinically Early-Stage Non-Small Cell Lung Cancer for Segmentectomy?
Deng, Han-Yu
Tang, Xiaojun
Zhou, Qinghua
Sichuan, Chengdu
CHEST, 2021, 159 (01) : 444 - 445
[37] Surgery for Early-Stage Small Cell Lung Cancer
Schneider, Bryan J.
Saxena, Ashish
Downey, Robert J.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10): : 1132 - 1139
[38] Stereotactic Ablative Radiation Therapy (SABR) for Early-Stage Lung Cancer in the Multicenter Community Setting
Fernandez, E.
Shulman, J. M.
Finkelstein, S. E.
Myslicki, F.
Mantz, C. A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S663 - S664
[39] Surgery versus SABR for early-stage lung cancer-time to call it a draw? Comment
Louie, Alexander, V
Tjong, Michael C.
Siva, Shankar
LANCET ONCOLOGY, 2021, 22 (10): : 1355 - 1357
[40] The case for SABR as the global standard for non-operable early-stage non-small cell lung cancer
Mutsaers, Adam
Louie, Alexander, V
Moraes, Fabio Ynoe
LANCET REGIONAL HEALTH-AMERICAS, 2022, 14

← 1 2 3 4 5 →